Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia

INTRODUCTION: Despite considerable scientific debate, there have been no prospective clinical studies on the effects of angiotensin II receptor blockers (ARBs) on the course of COVID-19 infection. Losartan is the ARB that was chosen to be tested in this study. METHODS: Patients with COVID-19 and mil...

Descripción completa

Detalles Bibliográficos
Autores principales: Geriak, Matthew, Haddad, Fadi, Kullar, Ravina, Greenwood, Kristina L., Habib, MacKenzie, Habib, Cole, Willms, David, Sakoulas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112834/
https://www.ncbi.nlm.nih.gov/pubmed/33977506
http://dx.doi.org/10.1007/s40121-021-00453-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112834/
https://www.ncbi.nlm.nih.gov/pubmed/33977506
http://dx.doi.org/10.1007/s40121-021-00453-3

Ejemplares similares